Issue link: https://www.e-digitaleditions.com/i/1300450
www.biopharminternational.com October 2020 BioPharm International eBook 49 Regulatory Sourcebook Quality transformation of the manufac- t uring env ironment create new challenges for industry, academia, and government. Collaboration on issues of science and regulation w ithin the IQ Consor tium can help meet these challenges and support continued innovation in the pharmaceutical research and development process. While celebrating the accom- pl ish ments of t he f i rst decade o f t h e I Q C o n s o r t i u m , I Q Consor tium members continue to preserve and refine the attri- butes that have been important for its success. The IQ Consortium is well equipped with excellent technical depth across many dis- ciplines. The frequency and mag- nitude of change in the broader scientific community is unprec- edented, and the IQ Consortium is well positioned to continue as an influential presence across the broad scientific landscape of phar- maceutical research and develop- ment. The IQ Consortium's past ac h ieve me nt s a nd publ ic at ion record demonst rate t hat i n no - vation and qualit y in phar ma- ceutical development remain its foundation, a goal that will con- tinue to drive the consortium well into its next decade. REFERENCES 1. O. J. Wouters, M. McKee, and J. Luyten, JAMA, 323 (9), 844-853 (2020). 2. J.S. Altshuler, et al., Sci Transl Med, 2 (52) 1-4 (2010). 3. S. Holmes, et al., Inhalation (February 2016). 4. H. Laverty and M. Goldman, Biotechnol J, 9 (9) 1095-6 (2014). 5. R. Ormiston, J. Schumacher, and L. Shtohryn, Inhalation (October 2011). 6. G. Paillard, et al., Drug Discov Today, 21 (1) 97-102 (2016). 7. J. M. Vergis, et al., LC GC North America, 33 (4) 270-281(2015). 8. J. A. Wagner, et al., Clin Pharmacol Ther, 87 (5) 539-42 (2010). 9. C. J. Welch, et al., Organic Process Research & Development, 21 (3) 414- 419 (2017). 10. J. Woodcock, et al., Nat Rev Drug Discov, 13 (11) 781 (2014). 11. M. Patlak, J Natl Cancer Inst, 102 (12) 841-3 (2010). 12. N. Savage, Nature, 533 (7602) S56-8 (2016). 13. J.A. Wagner, Clin Pharmacol Ther, 87 (5) 511-5 (2010). 14. J. Woodcock, Clin Pharmacol Ther, 87(5) 521-3 (2010). 15. American Association of Pharmaceutical Scientists (AAPS), www.aaps.org. 16. International Society for Pharmaceutical Engineering (ISPE), https://ispe.org. 17. Pharmaceutical Research and Manufacturers of America (PhRMA), www.phrma.org. 18. European Federation of Pharmaceutical Industries and Associations (EFPIA), www.efpia.eu. 19. American Society for Clinical Pharmacology and Therapeutics (ASCPT), www.ascpt.org. 20. J.M. Vergis and D.E. Vanderwall, Pharmaceutical Technology, Analytical and Bioanalytical eBook (3) 29-31 (2014). BP Connect with BIOPHARMINTERNATIONAL.COM Twitter.com/BioPharmIntl LinkedIn.com/company/ BioPharm-International Sign up for our eNewsletters Get the latest news, research, and trends in the biopharmaceutical industry delivered straight to your inbox by signing up. BP_Social_HouseAds_101420.indd 2 BP_Social_HouseAds_101420.indd 2 10/14/20 2:57 PM 10/14/20 2:57 PM